Field Trip Health Ltd. Shares Rise 5.8% Amid Increased Trading Volume

LOS ANGELES- Field Trip Health Ltd. experienced a 5.8% increase in its share price during trading on Tuesday. The stock reached a high of C$1.11, before settling at C$1.09 by the end of the trading day. This represents a notable rise from its previous close at C$1.03. The trading volume saw a significant surge, with approximately 97,451 shares traded, a 165% increase from the average daily volume of 36,819 shares.

The company’s financial metrics show a debt-to-equity ratio of 43.39, indicating a moderate level of debt relative to equity. Additionally, it has a quick ratio of 7.70 and a current ratio of 8.20, suggesting strong liquidity positions. The stock’s 50-day moving average is C$1.09, and the company’s market capitalization stands at C$12.68 million. The price-to-earnings ratio is -1.22, reflecting negative earnings.

Field Trip Health Ltd. specializes in developing and providing psychedelic-assisted therapies across North America. The company operates several Field Trip Health Centres offering psychedelic therapies and ketamine-assisted treatments for conditions such as depression, anxiety, and addiction. Additionally, it has a digital platform, Field Trip Digital apps, and a research and development division, Field Trip Discovery, focused on developing new psychedelic molecules.